Preclinical evaluation of an 111 In/ 225 Ac theranostic targeting transformed MUC1 for triple negati...
Preclinical evaluation of an 111 In/ 225 Ac theranostic targeting transformed MUC1 for triple negative breast cancer
About this item
Full title
Author / Creator
Publisher
Australia
Journal title
Language
English
Formats
Publication information
Publisher
Australia
Subjects
More information
Scope and Contents
Contents
: Transformed MUC1 (tMUC1) is a cancer-associated antigen that is overexpressed in >90% of triple-negative breast cancers (TNBC), a highly metastatic and aggressive subtype of breast cancer. TAB004, a murine antibody targeting tMUC1, has shown efficacy for the targeted delivery of therapeutics to cancer cells. Our aim was to evaluate humanized TAB0...
Alternative Titles
Full title
Preclinical evaluation of an 111 In/ 225 Ac theranostic targeting transformed MUC1 for triple negative breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_7150_thno_38236
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_7150_thno_38236
Other Identifiers
ISSN
1838-7640
E-ISSN
1838-7640
DOI
10.7150/thno.38236
